Filed Under:

New Drug Focuses Attention On HIV Prevention

Play associated audio
Following the FDA approval of Truvada — the once-a-day pill that can drastically lower a person's risk of contracting HIV — Audie Cornish talks with Dr. Wafaa El-Sadr of Columbia University's Mailman School of Public Health. They examine the status of HIV prevention efforts in the U.S. today — what progress has been made and the challenges that still ahead. El-Sadr has worked on HIV/AIDS prevention and treatment since 1981.
NPR

Tabasco And Beer-Flavored: Not Your Easter Bunny's Jelly Beans

On the eve of Easter and National Jelly Bean Day, let us probe the mysterious origins and unexpected ascendency of the humble candy. And to celebrate, we've sampled Jelly Belly's newest flavors.
NPR

Tabasco And Beer-Flavored: Not Your Easter Bunny's Jelly Beans

On the eve of Easter and National Jelly Bean Day, let us probe the mysterious origins and unexpected ascendency of the humble candy. And to celebrate, we've sampled Jelly Belly's newest flavors.
NPR

Obama's Favorite County — At Least When It Comes To Giving Speeches

The president has visited Prince George's County, Md., four times this year. It is the most affluent county with an African-American majority. It also happens to be very close to the White House.
NPR

Ohio's Law Against Political Lying Heads To Supreme Court

Can a state law prevent political campaigns from doling out misinformation? Guest host Celeste Headlee learns more from The Plain Dealer's Sabrina Eaton.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.